Hsa_circ_0012152 and Hsa_circ_0001857 Accurately Discriminate Acute Lymphoblastic Leukemia From Acute Myeloid Leukemia
- PMID: 32984037
- PMCID: PMC7492294
- DOI: 10.3389/fonc.2020.01655
Hsa_circ_0012152 and Hsa_circ_0001857 Accurately Discriminate Acute Lymphoblastic Leukemia From Acute Myeloid Leukemia
Abstract
Acute leukemia (AL) is a group of highly heterogeneous hematological malignancies. Circular RNAs (circRNAs) are covalently closed circRNA molecules implicated in the development of many diseases. However, the role of circRNAs in AL remains largely unknown. Therefore, this study aimed to identify new classification diagnostic biomarkers for subgroups of AL. The circRNA expression signatures discriminating acute lymphoblastic leukemia (ALL) from acute myeloid leukemia (AML) were identified by microarray, followed by reverse transcription quantitative polymerase chain reaction (RT-qPCR) validation. Receiver operating characteristic curve analysis was used to evaluate the diagnostic efficiencies of hsa_circ_0001857 and hsa_circ_0012152, and hsa_circ_0012152 was selected for Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis. The results showed that the circRNA expression profiles, hsa_circ_0001857, and hsa_circ_0012152 could clearly discriminate ALL from AML. The target genes of hsa_circ_0012152 might be involved in biological processes, such as myeloid cell differentiation, covalent chromatin modification, histone modification, and rat sarcoma (Ras) protein signal transduction, and participate in pathways such as mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3'-kinase (PI3K)-Akt signaling pathway. Hsa_circ_0012152 might be involved in the initiation and development of AML through miR-491-5p/epidermal growth factor receptor (EGFR)/MAPK1 or miR-512-3p/EGFR/MAPK1 axis. Our results showed that circRNA expression profiles and specifically expressed circRNAs were promising classification biomarkers to designate AL into ALL or AML.
Keywords: acute lymphoblastic leukemia; acute myeloid leukemia; bioinformatics; biomarker; circRNA.
Copyright © 2020 Guo, Li, Chen, Zou, Yang, Zhang, Wu, Sheng, Huang, Ouyang and Mu.
Figures







Similar articles
-
Distinguishing acute leukemia subtypes: The role of hsa_circ_0012152 and hsa_circ_0020093 in peripheral blood.Oncol Lett. 2025 May 7;30(1):330. doi: 10.3892/ol.2025.15076. eCollection 2025 Jul. Oncol Lett. 2025. PMID: 40385694 Free PMC article.
-
Construction of circRNA-miRNA-mRNA Network Reveal Functional circRNAs and Key Genes in Acute Myeloid Leukemia.Int J Gen Med. 2023 Apr 24;16:1491-1504. doi: 10.2147/IJGM.S402671. eCollection 2023. Int J Gen Med. 2023. PMID: 37123885 Free PMC article.
-
Identification of Circulating hsa_circ_0063425 and hsa_circ_0056891 as Novel Biomarkers for Detection of Type 2 Diabetes.J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2688-e2699. doi: 10.1210/clinem/dgab101. J Clin Endocrinol Metab. 2021. PMID: 33608702
-
Research on the circular RNA bioinformatics in patients with acute myocardial infarction.J Clin Lab Anal. 2021 Feb;35(2):e23621. doi: 10.1002/jcla.23621. Epub 2020 Oct 15. J Clin Lab Anal. 2021. PMID: 33063376 Free PMC article.
-
Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia.Front Oncol. 2023 Apr 14;13:1149187. doi: 10.3389/fonc.2023.1149187. eCollection 2023. Front Oncol. 2023. PMID: 37124518 Free PMC article. Review.
Cited by
-
The functions and clinical significance of circRNAs in hematological malignancies.J Hematol Oncol. 2020 Oct 17;13(1):138. doi: 10.1186/s13045-020-00976-1. J Hematol Oncol. 2020. PMID: 33069241 Free PMC article. Review.
-
Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasone.Ann Hematol. 2024 Jan;103(1):141-151. doi: 10.1007/s00277-023-05468-z. Epub 2023 Sep 26. Ann Hematol. 2024. PMID: 37749318
-
Overexpression miR-520a-3p inhibits acute myeloid leukemia progression via targeting MUC1.Transl Oncol. 2022 Aug;22:101432. doi: 10.1016/j.tranon.2022.101432. Epub 2022 May 29. Transl Oncol. 2022. PMID: 35649317 Free PMC article.
-
Prognostic and therapeutic implications of iron-related cell death pathways in acute myeloid leukemia.Front Oncol. 2023 Sep 5;13:1222098. doi: 10.3389/fonc.2023.1222098. eCollection 2023. Front Oncol. 2023. PMID: 37736548 Free PMC article.
-
Circular RNA as a Biomarker for Diagnosis, Prognosis and Therapeutic Target in Acute and Chronic Lymphoid Leukemia.Cell Biochem Biophys. 2024 Sep;82(3):1979-1991. doi: 10.1007/s12013-024-01404-8. Epub 2024 Aug 13. Cell Biochem Biophys. 2024. PMID: 39136839 Review.
References
-
- Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. Who Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th ed. Lyon: IARC. (2017).
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous